Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInventory AverageInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Unicycive Therapeutics (UNCY) Equity Ratio (2020 - 2026)

Unicycive Therapeutics filings provide 4 years of Equity Ratio readings, the most recent being 0.23 for Q4 2024.

  • On a quarterly basis, Equity Ratio rose 187.42% to 0.23 in Q4 2024 year-over-year; TTM through Dec 2024 was 0.23, a 187.42% increase, with the full-year FY2024 number at 0.23, up 187.42% from a year prior.
  • Equity Ratio hit 0.23 in Q4 2024 for Unicycive Therapeutics, up from 0.72 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.88 in Q4 2021 to a low of 0.85 in Q2 2023.
  • Median Equity Ratio over the past 4 years was 0.17 (2022), compared with a mean of 0.0.
  • The widest YoY moves for Equity Ratio: up 187.42% in 2024, down 508.76% in 2024.
  • Unicycive Therapeutics' Equity Ratio stood at 0.88 in 2021, then tumbled by 118.8% to 0.17 in 2022, then plummeted by 62.31% to 0.27 in 2023, then soared by 187.42% to 0.23 in 2024.
  • The last three reported values for Equity Ratio were 0.23 (Q4 2024), 0.72 (Q3 2024), and 0.33 (Q2 2024) per Business Quant data.